Journal
GROWTH FACTORS
Volume 30, Issue 2, Pages 88-106Publisher
TAYLOR & FRANCIS LTD
DOI: 10.3109/08977194.2012.660936
Keywords
JAK; STAT; signalling; cytokine; receptor; SOCS
Categories
Funding
- National Health and Medical Research Council (NHMRC), Australia [461219]
- National Institutes of Health, USA [CA022556-33]
Ask authors/readers for more resources
Since its discovery two decades ago, the activation of the Janus kinase/signal transducers and activators of transcription (JAK/STAT) pathway by numerous cytokines and growth factors has resulted in it becoming one of the most well-studied intracellular signalling networks. The field has progressed from the identification of the individual components to high-resolution crystal structures of both JAK and STAT, and an understanding of the complexities of the molecular activation and deactivation cycle which results in a diverse, yet highly specific and regulated pattern of transcriptional responses. While there is still more to learn, we now appreciate how disruption and deregulation of this pathway can result in clinical disease and look forward to adoption of the next generation of JAK inhibitors in routine clinical treatment.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available